Mucormycosis is a severe, rare fungal infection caused by a group of molds known as mucoromycetes. Although it usually has no impact on healthy people, it can lead to fatal disease in people with weak immune systems, such as those undergoing cancer therapy, uncontrolled diabetes, or recovering from COVID-19.
Usually impacting the sinuses, brain, lungs, or skin, the black fungal infection can swiftly permeate the whole body if not treated promptly. Managing the illness effectively depends on understanding its symptoms.
Read ahead to understand the symptoms of black fungal disease, its risk factors, diagnosis, and possible treatments.
Symptoms of mucormycosis (black fungal disease) vary depending on the part of the body affected. The most common symptoms are listed below, according to their different types:
If the infection spreads, patients might show a mix of these symptoms. Rapid diagnosis and treatment are essential since the condition might be fatal if untreated or cause significant tissue damage.
Usually, mucormycosis (black fungal disease) affects people with weakened immunity. The following conditions or treatments may raise your risk:
During the COVID-19 epidemic, cases of black fungus among COVID-19 recovering patients increased as a result of steroid overuse and underlying diabetes, particularly in India.
Mucormycosis diagnosis calls for a clinical exam and diagnostic testing, including:
The treatment of black fungal disease includes the following:
Black fungal disease is a rapidly spreading and lethal infection that primarily affects immunocompromised people. Although rare, its aggressive nature calls for immediate medical attention. Early symptom recognition, control of underlying health issues, and initiating prompt antifungal medication can help avoid fatal consequences.
Thus, it is essential to have health insurance to secure your health and finances at critical times. At Star Health, our insurance policies cover a wide range of health conditions. We provide hassle-free claim settlements with reduced turnaround time across over 14,000 network hospitals.